GlassScriptPhysician profile
Olivia Chapman
NPI 1770343832
$1,077.75
in general payments reported to CMS, 2019-2025
13 companies · $848 in 2025
The $848 reported for 2025 was more than what 85% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
See the full distribution for Plastic Surgery within the Head & Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $229 · 2025: $848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,077.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $199.34 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $180.52 | 2024-2025 | Nucala |
| Davol INC. | $133.38 | 2025 | Arista |
| Kerecis Limited | $115.91 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Genzyme Corporation | $100.10 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $95.49 | 2025 | Dupixent |
| Medtronic, INC. | $78.78 | 2025 | Propel |
| Stryker Corporation | $78.38 | 2025 | Scopis Ent, Na |
| Cochlear Americas | $24.51 | 2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Acera Surgical, INC. | $18.98 | 2025 | Restrata Wound Matrix |
| Atos Medical INC | $18.61 | 2025 | Provox Life Home Hme |
| Phadia US INC. | $17.19 | 2025 | Immunocap |
| Smith+Nephew, INC. | $16.56 | 2024 | Coblation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.